[1]. Remuzzi A, Remuzzi G. (2020). COVID-19 and Italy: what next? .The Lancet, 395(10231), 1225-1228.
[2]. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J. (2020). Coronavirus infections and immune responses. Journal of Medical Virology, 92(4), 424-432.
[3]. Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, Liu W, Bi W, Gao G. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology, 24(6), 490-502.
[4]. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395(10224), 565-574.
[5]. Li J-Y, You Z, Wang Q, Zhou Z-J, Qiu Y, Luo R, Ge X-Y. (2020). The epidemic of 2019-novel-coronavirus [2019-nCoV] pneumonia and insights for emerging infectious diseases in the future. Microbes and Infection, 22(2), 80-85.
[6]. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang Xi, Zheng X-S, Zhao K, Chen Q-J, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270-273.
[7]. Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, Hu Y, Tao Z-W, Tian J-H, Pei Y-Y, Yuan M-L, Zhang Y-L, Dai F-H, Liu Y, Wang Q-M, Zheng J-J, Xu L, Holmes E, Zhang Y-Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265-269.
[8]. Ji W, Wang W, Zhao X, Zai J, Li X. (2020). Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. Journal of Medical Virology. doi.org/10.1002/jmv.25682
[9]. Ji W, Wang W, Zhao X, Zai J, Li X. (2020). Cross-species transmission of the newly identified coronavirus 2019-nCoV. Journal of Medical Virology, 92(4), 433-440.
[10]. Nadeem MS, Zamzami MA, Choudhry H, Murtaza BN, Kazmi I, Ahmad H, Shakoori AR. (2020). Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19). Pathogens, 9(4), 307. https://doi.org/10.3390/pathogens9040307
[11]. Walls A-C, Park Y-J, Tortorici M-A, Wall A, McGuire A-T, Veesler D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 181(2), 281-292.
[12]. Hoffmann M, Kleine-Weber H, Krüger N, Mueller MA, Drosten C, Pöhlmann S. (2020). The novel coronavirus 2019 [2019-nCoV] uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells, BioRxiv. doi.org/10.1101/2020.01.31.929042
[13]. Qi F, Qian S, Zhang S, Zhang Z. (2020). Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochemical and Biophysical Research Communications, 526(1), 135-140.
[14]. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
[15]. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. (2020). Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology, 295(3), 715–721.
[16]. Yin Y, Wunderink RG. (2018). MERS, SARS and other coronaviruses as causes of pneumonia. Respirology, 23(2), 130-137.
[17]. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK,et al.(2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.Eurosurveillance,25(3).https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045
[18]. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. (2020). Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 295(1), 210-217.
[19]. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. (2020). The proximal origin of SARS-CoV-2. Nature Medicine, 26(4), 450-452.
[20]. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. (2020). Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia. British Journal of Haematology. https://doi.org/10.1111/bjh.16797
[21]. Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. (2020). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 382(16), 1564-1567.
[22]. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. (2020) COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 24, 91-98.
[23]. Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, Liu R, He X, Shuai L, Sun Z, Zhao Y. (2020). Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science, 368(6494), 1016-1020.
[24]. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. (2020). Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences, 117(17), 9490-9496.
[۲۵]. یوسفی، رضا، موسوی موحدی، فائزه ، (1398)، ویروس کرونای جدید: از پیشگیری و درمان تا ساز و کار تکثیر و گسترش در بدن انسان، نشریه نشاء علم، سال دهم، شماره اول، صفحات 42-53.
)
